Literature DB >> 31913469

Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties.

Amanda L Patterson1,2, Jitu W George1, Anindita Chatterjee1, Tyler J Carpenter1, Emily Wolfrum3, David W Chesla1,4, Jose M Teixeira1.   

Abstract

STUDY QUESTION: Can endometrial stromal stem/progenitor cell markers, SUSD2 and CD146/CD140b, enrich for human myometrial and fibroid stem/progenitor cells? SUMMARY ANSWER: SUSD2 enriches for myometrial and fibroid cells that have mesenchymal stem cell (MSC) characteristics and can also be induced to decidualise. WHAT IS KNOWN ALREADY: Mesenchymal stem-like cells have been separately characterised in the endometrial stroma and myometrium and may contribute to diseases in their respective tissues. STUDY DESIGN, SIZE, DURATION: Normal myometrium, fibroids and endometrium were collected from hysterectomies with informed consent. Primary cells or tissues were used from at least three patient samples for each experiment. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Flow cytometry, immunohistochemistry and immunofluorescence were used to characterise tissues. In vitro colony formation in normoxic and hypoxic conditions, MSC lineage differentiation (osteogenic and adipogenic) and decidualisation were used to assess stem cell activity. Xenotransplantation into immunocompromised mice was used to determine in vivo stem-like activity. Endpoint measures included quantitative PCR, colony formation, trichrome, Oil Red O and alkaline phosphatase activity staining. MAIN RESULTS AND THE ROLE OF CHANCE: CD146+CD140b+ and/or SUSD2+ myometrial and fibroid cells were located in the perivascular region and formed more colonies in vitro compared to control cells and differentiated down adipogenic and osteogenic mesenchymal lineages in vitro. SUSD2+ myometrial cells had greater in vitro decidualisation potential, and SUSD2+ fibroid cells formed larger tumours in vivo compared to control cells. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Markers used in this study enrich for cells with stem/progenitor cell activity; however, they do not distinguish stem from progenitor cells. SUSD2+ myometrial cells express markers of decidualisation when treated in vitro, but in vivo assays are needed to fully demonstration their ability to decidualise. WIDER IMPLICATIONS OF THE
FINDINGS: These results suggest a possible common MSC for the endometrial stroma and myometrium, which could be the tumour-initiating cell for uterine fibroids. STUDY FUNDING/COMPETING INTEREST(S): These studies were supported by NIH grants to JMT (R01OD012206) and to ALP (F32HD081856). The authors certify that we have no conflicts of interest to disclose.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  endometrial stromal stem/progenitor cells; fibroids; mesenchymal stem cells; myometrium; stem/progenitor cells

Mesh:

Year:  2020        PMID: 31913469      PMCID: PMC6993861          DOI: 10.1093/humrep/dez247

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  55 in total

1.  Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.

Authors:  Peng Zhang; Cunxian Zhang; Jie Hao; C James Sung; M Ruhul Quddus; Margaret M Steinhoff; W Dwayne Lawrence
Journal:  Hum Pathol       Date:  2006-07-26       Impact factor: 3.466

Review 2.  Cyclic decidualization of the human endometrium in reproductive health and failure.

Authors:  Birgit Gellersen; Jan J Brosens
Journal:  Endocr Rev       Date:  2014-08-20       Impact factor: 19.871

Review 3.  Concise review: the surface markers and identity of human mesenchymal stem cells.

Authors:  Feng-Juan Lv; Rocky S Tuan; Kenneth M C Cheung; Victor Y L Leung
Journal:  Stem Cells       Date:  2014-06       Impact factor: 6.277

4.  The blood supply of the uterus. 1. Arterial vasculature.

Authors:  G Farrer-Brown; J O Beilby; M H Tarbit
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-08

5.  Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis.

Authors:  D P Lennon; J M Edmison; A I Caplan
Journal:  J Cell Physiol       Date:  2001-06       Impact factor: 6.384

6.  Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-gamma ligand, pioglitazone.

Authors:  C J Loy; S Evelyn; F K Lim; M H Liu; E L Yong
Journal:  Mol Hum Reprod       Date:  2005-07-28       Impact factor: 4.025

7.  A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables.

Authors:  Michael Smithson; Jay Verkuilen
Journal:  Psychol Methods       Date:  2006-03

8.  Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.

Authors:  Ping Yin; Masanori Ono; Molly B Moravek; John S Coon; Antonia Navarro; Diana Monsivais; Matthew T Dyson; Stacy A Druschitz; Saurabh S Malpani; Vanida A Serna; Wenan Qiang; Debabrata Chakravarti; J Julie Kim; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2015-02-06       Impact factor: 5.958

9.  Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2.

Authors:  Kavitha Sivasubramaniyan; Abhishek Harichandan; Susanne Schumann; Malgorzata Sobiesiak; Claudia Lengerke; Andreas Maurer; Hubert Kalbacher; Hans-Jörg Bühring
Journal:  Stem Cells Dev       Date:  2013-03-18       Impact factor: 3.272

10.  Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues.

Authors:  Sarah J Holdsworth-Carson; Marina Zaitseva; Beverley J Vollenhoven; Peter A W Rogers
Journal:  Mol Hum Reprod       Date:  2013-11-15       Impact factor: 4.025

View more
  7 in total

Review 1.  Uterine Fibroids: Hiding in Plain Sight.

Authors:  Elizabeth A Stewart; Romana A Nowak
Journal:  Physiology (Bethesda)       Date:  2022-01-01

Review 2.  Bioengineering of the Uterus.

Authors:  Yushi Yoshimasa; Tetsuo Maruyama
Journal:  Reprod Sci       Date:  2021-04-07       Impact factor: 3.060

Review 3.  Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities.

Authors:  Malak El Sabeh; Subbroto Kumar Saha; Sadia Afrin; Md Soriful Islam; Mostafa A Borahay
Journal:  Mol Cell Biochem       Date:  2021-05-17       Impact factor: 3.842

Review 4.  Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

Authors:  Qiwei Yang; Michal Ciebiera; Maria Victoria Bariani; Mohamed Ali; Hoda Elkafas; Thomas G Boyer; Ayman Al-Hendy
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

5.  Human Myometrial and Uterine Fibroid Stem Cell-Derived Organoids for Intervening the Pathophysiology of Uterine Fibroid.

Authors:  Saswati Banerjee; Wei Xu; Indrajit Chowdhury; Adel Driss; Mohamed Ali; Qiwei Yang; Ayman Al-Hendy; Winston E Thompson
Journal:  Reprod Sci       Date:  2022-05-18       Impact factor: 2.924

6.  Application Effect of Laparoscopic Myomectomy and Comprehensive Rehabilitation Nursing on Patients with Uterine Fibroids.

Authors:  Zhihong Liu; Zhiwen Gao; Fangwei Li; Lifen Xu; Xinghua Liu
Journal:  Comput Math Methods Med       Date:  2022-09-22       Impact factor: 2.809

Review 7.  Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications.

Authors:  Malak El Sabeh; Sadia Afrin; Bhuchitra Singh; Mariko Miyashita-Ishiwata; Mostafa Borahay
Journal:  Stem Cell Rev Rep       Date:  2020-11-05       Impact factor: 6.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.